ArticleBMC cardiovascular disorders2018

An early analysis of cost-utility of baroreflex activation therapy in advanced chronic heart failure in Germany.

Oleg Borisenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.